Clin Mol Hepatol.
2020 Apr;26(2):183-184. 10.3350/cmh.2020.0042.
Should you advocate for hepatocellular carcinomasurveillance in patients with alcohol-related liverdisease or non-alcoholic fatty liver disease?
- Affiliations
-
- 1Department of Gastroenterology, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
- KMID: 2500381
- DOI: http://doi.org/10.3350/cmh.2020.0042
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Hepatocellular Carcinoma Arising from Non-Cirrhotic Non-Alcoholic Steatohepatitis
- Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease
- A Case of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease
- Are patients with alcohol-related fatty liver at increased risk of coronary heart disease?
- Metabolic dysfunction-associated fatty liver disease is a ubiquitous latent cofactor in viral- and alcoholic-related hepatocellular carcinoma: Editorial on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis”
